NFC news in brief • 31 Jan 2011 By Sarah Clark • 31 January 2011 News in brief from the NFC world and beyond: Getyoo pings Belgacom • Mobey Forum expands • Clear2Pay goes to South Africa • Facebook takes the credit • Vancouver to go contactless • …and Philadelphia to...
MSD said, “I am thrilled to announce the appointment of Rehan A. Khan as Managing Director for MSD in India. Rehan is an accomplished international leader who has led large and complex multinational businesses, covering India, Greater China, Southeast Asia, and across Asia Pacific with leading ...
Evopoint Biosciences Co., Ltd.(“Evopoint”) announced today a collaboration with MSD (Merck & Co., Inc., Rahway, NJ, USA) to evaluate Evopoint’s XNW5004, a selective EZH2 inhibitor, in combination with KEYTR...
Sign Up Sign in to manage your newsletters » Sign up to receive the latest updates from U.S. News & World Report and our trusted partners and sponsors. By clicking submit, you are agreeing to our Terms and Conditions & Privacy Policy. You May Also Like The 10 Wor...
human papillomavirus (HPV) in their lifetime, making it a prevalent health concern. However, the good news is that proactive screening plays a crucial role in preventing cervical cancer. Regular screening allows for the early detection of abnormal ...
4D's proprietary MicroRx® platform will be paired with MSD's expertise in the development and commercialisation of novel vaccines
新内容 版本记录 版本5.6.24000 - Added the ability to upload images and files from Google Drive and One Drive in Reach - Added the ability for Districts to change or modify branding color within the Portal - Minor Bug Fixes and Improvements...
MSD’s attempt to expand the indication of its Covid-19 oral treatment Lagevrio (molnupravir) to post-exposure preventive treatment has ended in failure.MSD said Tuesday (local time) that it failed to prove the efficacy of Lagebrio in post-exposure preve
MSD had expected that its pneumococcal vaccine Vaxneuvance would obtain expanded indication for children and infants by April, but the FDA recently pushed back the review date for the drug.With the possibility of the delay in the expanded indication, MSD
Totech Super DryR opens new factory as MSD awareness accelerates in the Americas.Totech America